Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 241 - 260 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Global Veterinary Vaccines Markets, 2018-2019 & 2024 - Increasing Adoption of Veterinary Vaccines for Quality Food Products and Better Animal Health

DUBLIN, April 24, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019

New data on sepsis outcomes in hospitals shows how fatalities can be reduced

MANHASSET, N.Y., April 24, 2019 /PRNewswire/ -- Martin E. Doerfler, MD, Northwell Health... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019

Charity Creates Line Of Baby Products For Newborns Withdrawing From Heroin And Opioids

NEW YORK, April 24, 2019 /PRNewswire/ -- Every 15 minutes a baby is born withdrawing from opioid dependency - primarily because their mothers have little-to-no access to treatment for their substance use disorder. As this crisis hits critical mass, the Urgent Love Initiative of Roanoke, VA has... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019
Related companies:  Greystone Research Associates | Grey Sky Venture Partners | Greylock Partners | Greycroft

Points to Consider in the Reevaluation and Reanalysis of Genomic Test Results: A Statement of the American College of Medical Genetics and Genomics (ACMG)

BETHESDA, Md., April 24, 2019 /PRNewswire/ -- Advances in genetic testing have enabled clinical laboratories to provide increasingly comprehensive genetic testing. Now, in an effort to provide guidance on the important topic of the later reanalysis of genetic testing results, the American College... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019

Bausch Health Companies Announces Participation In Upcoming Investor Conferences

LAVAL, Quebec, April 24, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the Company will participate in four investor conferences in May.

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2019
Related companies:  Bausch Health Companies Inc.

Oxurion NV announces full enrollment in its Phase 1 trial evaluating the safety of its plasma kallikrein inhibitor THR-149 for treatment of DME, ahead of schedule

Read more ››
By: Nasdaq / GlobenewsWire - 24 Apr 2019

Interim report for the first 3 months of 2019

Read more ››
By: Nasdaq / GlobenewsWire - 24 Apr 2019
Related companies:  Novozymes A/S

CellaVision AB presents the first quarter for 2019 on May 7 at 11:00 CET

Read more ››
By: Nasdaq / GlobenewsWire - 24 Apr 2019
Related companies:  CELLAVISION AB

Professor Paul Fitzgerald joins Nexstim's Scientific Advisory Board

Read more ››
By: Nasdaq / GlobenewsWire - 24 Apr 2019

Amarin To Report First Quarter 2019 Results and Host Conference Call On May 1, 2019

Read more ››
By: Nasdaq / GlobenewsWire - 24 Apr 2019
Related companies:  Amarin Corporation plc

Integra LifeSciences Reports First Quarter 2019 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 24 Apr 2019
Related companies:  Integra Lifesciences Holdings Corp

EPS International and George Clinical Form Strategic Partnership for the Asia-Pacific Region

SYDNEY, April 24, 2019 /PRNewswire/ -- George Clinical and EPS International Holdings Co., Ltd. announced today that they have reached an agreement on a strategic partnership that will enhance their combined service offerings in Asia-Pacific, the world's most populous region, as well as worldwide... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019
Related companies:  GEORGE CLINICAL PTY LTD

Oncopeptides Provides New Guidance on the Patient Recruitment in the OCEAN Study and a Clinical Program Update in a Webcast at 10:00 (CET)

STOCKHOLM, April 24, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that the company will provide an update on patient recruitment in the ongoing phase 3 study OCEAN, as well as a general update from all the company's clinical studies in a webcast at 10.00am... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019
Related companies:  Oncopeptides AB

IRRAS Provides Update on CE Mark Re-Certification of IRRAflow®

STOCKHOLM, April 24, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical technology company focused on developing and commercializing innovative solutions for neurocritical care, announced today that it received a response from G-MED, its designated European... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019
Related companies:  IRRAS AB

Immunovia Interim Report, January-March 2019

STOCKHOLM, April 24, 2019 /PRNewswire/ -- During the first quarter of 2019, we remained focused on our product launch strategy and continued to create value, as we reached several key objectives and took several steps towards the commercialization of IMMray(TM) PanCan-d, our diagnostic test for... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019
Related companies:  Immunovia AB

Can a novel, temporary, and fully resorbable surgical implant improve the outcome of common hockey and soccer injuries?

UPPSALA, Sweden, April 24, 2019 /PRNewswire/ -- Researchers of the Erasmus University Medical Center in Rotterdam - the Netherlands, consider that the synthetic and fully resorbable TIGR┬« Matrix surgical mesh (Novus Scientific AB, Uppsala - Sweden) may reduce frequent risks related to the surgical... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019

Emendo Biotherapeutics Enters Into Licensing Option Agreement With Takeda for its OMNI Nuclease Program

NEW YORK, April 24, 2019 /PRNewswire/ -- Emendo Biotherapeutics Inc today announced that the company signed a licensing option agreement with Takeda Pharmaceutical Company Limited. As part of the transaction, Emendo will receive an investment... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019

Visiongain Report Offers Transformative Insights on the $11.8bn Anaesthesia Drugs Market

Global Anaesthesia Drugs Market 2019-2029

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2019

Globe Life Sciences Finds That Tinnitus Represents an Untapped Commercial Opportunity

New report from Globe Life Sciences identifies tinnitus to be an attractive but under-recognised commercial opportunity for pharmacotherapies to target

Read more ››
By: PR Newswire Association LLC. - 24 Apr 2019

Medical X-Ray Market Value to Hit $16.5 Billion by 2025: Global Market Insights, Inc.

SELBYVILLE, Del., April 24, 2019 /PRNewswire/ -- China's medical X-ray market held significant revenue share in 2018 and is estimated to witness more than 8% CAGR over the forecast timeframe. Increasing prevalence of chronic diseases and a consequential rise in need for diagnoses will drive China... Read more ››

By: PR Newswire Association LLC. - 24 Apr 2019
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑